Selig misspoke on mention markets as Duffy pressed manipulation case

Terry Duffy had been building toward something for several hours before he got there. The roundtable inside the CFTC's Washington headquarters had moved through crypto asset management and agentic finance at the pace these things move — methodically, without incident — and then the prediction markets panel began, and within minutes Duffy was citing three specific contracts he believed violated Core Principle 3: a derivative on Nicolas Maduro's removal, a sports-related contract, and trades placed by a former teleprompter operator for the President of the United States.

CFTC Chairman Michael Selig interjected that the products were "not listed" in the US — meaning they were offshore. The room accepted this. It was wrong. Gabriel Perez's mention market trades, which Kalshi's own surveillance team flagged and referred to the CFTC, were placed on Kalshi. The Maduro contract was offshore. Selig had collapsed two separate facts into one incorrect statement, in public, at the first meeting of his own Innovation Advisory Committee.

Selig's error did not resolve the underlying argument. Duffy's complaint about the self-certification process — 2,500 certifications since January 2025, none opposed — is a structural objection, not a case-by-case one. His position is that the absence of prior agency review has created space for contracts that should not exist. Kalshi's Luana Lopes Lara defended self-certification on speed grounds: prediction markets need to respond to events in real time. Both of these things can be true simultaneously, which is precisely why the exchange produced heat without resolution.

The personal exchange between Lopes Lara and Duffy has drawn more attention than it probably deserves. When she pointed out that CME's regulatory headcount might be an argument for inefficiency rather than rigor, she landed a clean line. It will not change Duffy's position or CME's institutional interest in a more tightly supervised competitor landscape. The subtext of every objection CME raises about Kalshi is that CME operates under a regulatory burden that Kalshi currently does not share. That is a legitimate grievance dressed as a safety concern, and it is sometimes both at once.

Robinhood's Vlad Tenev stopped short of calling for a ban on mention markets, which is the more interesting data point from his appearance. Tenev's reluctance to foreclose the category suggests he sees the product as viable if the manipulation question gets answered — which is a different position than Duffy's, even if both men arrived at the same panel.

What the meeting produced, concretely, was Selig's three-part roadmap: amendments to the prohibited-contract rules, modernized reporting for fully collateralized contracts, and new rules on how designated contract markets list event contracts and protect consumers. No follow-up meeting was scheduled. A roadmap without a calendar is a statement of intent, and the CFTC's stated intent has been visible for months. The gap between intent and rulemaking is where the legal contests currently live.